
Inside CVS Caremark: The Role of PBMs in Drug Costs & Access SPONSORED
Jun 3, 2026 - 25:21
Radio and PodcastLive Radio & Podcasts
Health Affairs ' Rob Lott interviews James Robinson of the University of California Berkeley about his recent paper exploring most favored nation drug pricing , weighing its feasibility, likely effects on drug launch pri...
What Most Favored Nation Drug Pricing Would Mean for the US is an episode from A Health Podyssey by Health Affairs. Health Affairs ' Rob Lott interviews James Robinson of the University of California Berkeley about his recent paper explorin...
This episode belongs to A Health Podyssey.
Use the player on this page to stream the episode online.
Published Apr 14, 2026, 23:55 long, audio available.
Health Affairs ' Rob Lott interviews James Robinson of the University of California Berkeley about his recent paper exploring most favored nation drug pricing , weighing its feasibility, likely effects on drug launch prices, and implications for global pharmaceutical innovation and investment. Order the April 2026 issue of Health Affairs .
You can listen to What Most Favored Nation Drug Pricing Would Mean for the US online on Radio and Podcast. Open the player on this page to stream the available audio.
What Most Favored Nation Drug Pricing Would Mean for the US is an episode from A Health Podyssey by Health Affairs.
This episode is 23:55 long.
This episode was published on Apr 14, 2026.
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Yes. This page shows related episodes from A Health Podyssey when more episodes are available from the podcast feed.
You can listen to What Most Favored Nation Drug Pricing Would Mean for the US on this page when the episode audio is available from the podcast feed.
What Most Favored Nation Drug Pricing Would Mean for the US is from A Health Podyssey by Health Affairs.
Published Apr 14, 2026 and 23:55 long